StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 889.00
+2.00 (0.23%)
Oct 16, 2025, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 9.11 billion as of October 16, 2025. Its market cap has decreased by -45.39% in one year.
Market Cap
9.11B
Enterprise Value
6.88B
Revenue
2.70B
Ranking
n/a
PE Ratio
36.34
Stock Price
889.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 9.11B, a decrease of -56.95%. That is a compound annual growth rate of -17.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 9.11B | -31.03% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.52T |
| HOYA Corporation | 7,219.41B |
| Daiichi Sankyo Company | 7,218.67B |
| Takeda Pharmaceutical Company | 6,604.11B |
| Otsuka Holdings | 4,172.24B |
| Terumo | 3,626.42B |
| Astellas Pharma | 2,839.43B |
| Shionogi & | 2,059.38B |